No paralogue variants have been mapped to residue 325 for KCNJ2.
| KCNJ2 | VVILEGMVEATAMTTQCRSSYLANEILWGH>R<YEPVLFEE-KHYYKVDYSRFHKTYEVPNTP | 354 |
| KCNJ1 | VVFLDGTVESTSATCQVRTSYVPEEVLWGY>R<FAPIVSKTKEGKYRVDFHNFSKTVEVET-P | 353 |
| KCNJ3 | VVILEGIVETTGMTCQARTSYTEDEVLWGH>R<FFPVISLE-EGFFKVDYSQFHATFEVP-TP | 354 |
| KCNJ4 | VVILEGMVEATAMTTQARSSYLASEILWGH>R<FEPVVFEE-KSHYKVDYSRFHKTYEVAGTP | 346 |
| KCNJ5 | VVILEGMVEATGMTCQARSSYMDTEVLWGH>R<FTPVLTLE-KGFYEVDYNTFHDTYETN-TP | 360 |
| KCNJ6 | VVILEGMVEATGMTCQARSSYITSEILWGY>R<FTPVLTLE-DGFYEVDYNSFHETYETS-TP | 363 |
| KCNJ8 | IVILEGVVETTGITTQARTSYIAEEIQWGH>R<FVSIVTEE-EGVYSVDYSKFGNTVKVA-AP | 351 |
| KCNJ9 | VVILEGMVEATGMTCQARSSYLVDEVLWGH>R<FTSVLTLE-DGFYEVDYASFHETFEVP-TP | 331 |
| KCNJ10 | VLILSGTVESTSATCQVRTSYLPEEILWGY>E<FTPAISLSASGKYIADFSLFDQVVKVAS-P | 339 |
| KCNJ11 | IVILEGVVETTGITTQARTSYLADEILWGQ>R<FVPIVAEE-DGRYSVDYSKFGNTVKVP-TP | 342 |
| KCNJ12 | VVILEGMVEATAMTTQARSSYLANEILWGH>R<FEPVLFEE-KNQYKIDYSHFHKTYEVPSTP | 355 |
| KCNJ13 | VVFLSAMQEGTGEICQRRTSYLPSEIMLHH>C<FASLLTRGSKGEYQIKMENFDKTVPEFPTP | 328 |
| KCNJ14 | VVILEGMVEATAMTTQCRSSYLPGELLWGH>R<FEPVLFQR-GSQYEVDYRHFHRTYEVPGTP | 359 |
| KCNJ15 | VVLLNATVESTSAVCQSRTSYIPEEIYWGF>E<FVPVVSLSKNGKYVADFSQFEQIRKSP--- | 337 |
| KCNJ16 | LVTFIYTGDSTGTSHQSRSSYVPREILWGH>R<FNDVLEVK-RKYYKVNCLQFEGSVEVY-AP | 337 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.R325C | c.973C>T | Putative Benign | rs202067116 | SIFT: deleterious Polyphen: possibly damaging |